Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial

John R. Petrie*, Nish Chaturvedi, Ian Ford, Irene Hramiak, Alun D. Hughes, Alicia J. Jenkins, Barbara E. Klein, Ron Klein, Teik Chye Ooi, Peter Rossing, Naveed Sattar, Coen D. A. Stehouwer, Helen M. Colhoun

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)509-516
Number of pages8
JournalDiabetes Obesity & Metabolism
Volume19
Issue number4
DOIs
Publication statusPublished - Apr 2017

Keywords

  • adjunct therapy
  • cardiovascular
  • carotid intima media thickness
  • clinical trial
  • complications
  • endothelial function
  • hypoglycaemia metformin
  • type 1 diabetes
  • weight
  • INTIMA-MEDIA THICKNESS
  • ACTIVATED PROTEIN-KINASE
  • PLACEBO-CONTROLLED TRIAL
  • GLYCEMIC CONTROL
  • VITAMIN-B-12 DEFICIENCY
  • POTENTIAL ROLE
  • PROGRESSION
  • DISEASE
  • ASSOCIATION
  • METABOLISM

Cite this

Petrie, J. R., Chaturvedi, N., Ford, I., Hramiak, I., Hughes, A. D., Jenkins, A. J., Klein, B. E., Klein, R., Ooi, T. C., Rossing, P., Sattar, N., Stehouwer, C. D. A., & Colhoun, H. M. (2017). Metformin in adults with type 1 diabetes: Design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): An international multicentre trial. Diabetes Obesity & Metabolism, 19(4), 509-516. https://doi.org/10.1111/dom.12840